Author:
Galvidis Inna A.,Moshcheva Anastasia G.,Surovoy Yury A.,Sobolev Pavel D.,Sharipov Vitaly R.,Sidorov Nikita G.,Tsarenko Sergei V.,Burkin Maksim A.
Reference26 articles.
1. Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens;Sutcliffe;Antimicrob. Agents Chemother.,2013
2. Eravacycline for the treatment of intra-abdominal infections;Bassetti;Expert Opin. Investig. Drugs,2014
3. Target-and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic;Grossman;Antimicrob. Agents Chemother.,2012
4. Eravacycline: a review in complicated intra-abdominal infections;Scott;Drugs,2019
5. Comparative in vitro activities of omadacycline, eravacycline and tigecycline against non-ESBL-producing, ESBL-producing and carbapenem-resistant isolates of K. pneumoniae;Mirza;J. Med. Microbiol.,2022